Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

BOULDER, Colo., May 12, 2014 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas and the UBS Global Healthcare Conference in New York City.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.   

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

SOURCE Array BioPharma Inc.